Search results
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents
Quartz· 5 days agoBoth companies reported quarterly earning Thursday, providing insights into how the drug...
...Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in...
Morningstar· 7 days agoThe VERSATILE-002 trial is evaluating Versamune® HPV (formerly PDS0101) in combination with the immune checkpoint...
British man tests first personalised melanoma vaccine
BBC via Yahoo News· 4 days agoUniversity College London Hospitals (UCLH) doctors are giving it alongside another drug,...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Reuters· 5 days ago, opens new tab on Thursday raised its annual profit and revenue forecast on the back of strong...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 5 days agoThe Zacks Consensus Estimate for 2024 EPS has declined from $11.13 per share to $11.12 over the past...
Cancer breakthrough as scientists develop jab that could provide miracle cure
Daily Express· 5 days agoA revolutionary skin cancer vaccine being tested on British patients offers hope of a cure for the...
UPDATE 3-Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
Reuters via Yahoo Finance· 5 days agoMerck & Co on Thursday raised its annual profit and revenue forecasts on the back of double-digit growth for its blockbuster cancer drug Keytruda, the world's top selling ...
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
Benzinga via Yahoo Finance· 6 days agoThe investigational immuno-oncology combination demonstrates an overall response rate (ORR) of...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 5 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Man’s ‘bump on head’ turns out to be sign of skin cancer
Yahoo Life UK· 4 days agoYoung, who had the melanoma growth cut out of his scalp last August, is one of the first patients to...